|Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis|
E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ...
The Lancet Infectious Diseases 18 (3), 318-327, 2018
|Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data|
TP Van Boeckel, S Gandra, A Ashok, Q Caudron, BT Grenfell, SA Levin, ...
The Lancet infectious diseases 14 (8), 742-750, 2014
|Global increase and geographic convergence in antibiotic consumption between 2000 and 2015|
EY Klein, TP Van Boeckel, EM Martinez, S Pant, S Gandra, SA Levin, ...
Proceedings of the National Academy of Sciences 115 (15), E3463-E3470, 2018
|Antimicrobial stewardship programmes in health-care facilities in low-and middle-income countries: a WHO practical toolkit|
World Health Organization
World Health Organization, 2019
|Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis|
P Collignon, JJ Beggs, TR Walsh, S Gandra, R Laxminarayan
The Lancet Planetary Health 2 (9), e398-e405, 2018
|The state of the world's antibiotics 2015|
H Gelband, M Miller, Petrie, S Pant, S Gandra, J Levinson, D Barter, ...
Wound healing southern africa 8 (2), 30-34, 2015
|Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study|
A Teillant, S Gandra, D Barter, DJ Morgan, R Laxminarayan
The Lancet infectious diseases 15 (12), 1429-1437, 2015
|Economic burden of antibiotic resistance: how much do we really know?|
S Gandra, DM Barter, R Laxminarayan
Clinical microbiology and infection 20 (10), 973-980, 2014
|Surveillance for control of antimicrobial resistance|
E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ...
The Lancet Infectious Diseases 18 (3), e99-e106, 2018
|Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe|
M Sharland, C Pulcini, S Harbarth, M Zeng, S Gandra, S Mathur, ...
The Lancet Infectious Diseases 18 (1), 18-20, 2018
|The selection and use of essential medicines: report of the WHO Expert Committee, 2015 (including the 19th WHO Model List of Essential Medicines and the 5th WHO Model List of …|
World Health Organization
World Health Organization, 2015
|Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries|
Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ...
The Lancet Global Health 7 (7), e861-e871, 2019
|Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data|
EY Klein, M Milkowska-Shibata, KK Tseng, M Sharland, S Gandra, ...
The Lancet Infectious Diseases 21 (1), 107-115, 2021
|Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach|
C Pulcini, F Binda, AS Lamkang, A Trett, E Charani, DA Goff, S Harbarth, ...
Clinical Microbiology and Infection 25 (1), 20-25, 2019
|Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014|
S Gandra, N Mojica, EY Klein, A Ashok, V Nerurkar, M Kumari, U Ramesh, ...
International Journal of Infectious Diseases 50, 75-82, 2016
|The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study|
S Gandra, KK Tseng, A Arora, B Bhowmik, ML Robinson, B Panigrahi, ...
Clinical Infectious Diseases 69 (4), 563-570, 2019
|Scoping report on antimicrobial resistance in India|
S Gandra, J Joshi, A Trett, AL Sankhil, R Laxminarayan
Center for Disease Dynamis, Economics & Policy, 2017
|Carbapenem-resistant enterobacteriaceae in children, United States, 1999–2012|
LK Logan, JP Renschler, S Gandra, RA Weinstein, R Laxminarayan, ...
Emerging infectious diseases 21 (11), 2014, 2015
|European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli …|
M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ...
Clinical Microbiology and Infection 28 (4), 521-547, 2022
|Antibiotic prescription practices in primary care in low-and middle-income countries: a systematic review and meta-analysis|
G Sulis, P Adam, V Nafade, G Gore, B Daniels, A Daftary, J Das, S Gandra, ...
PLoS medicine 17 (6), e1003139, 2020